Skip to main content

RegMedNet is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Journal
    • Our Journals
    • Journal content
    • Journal articles

    Follow us on social media

  • News
  • Topics
    • CAR-T
      • Stem cells
      • Cell therapy
      • Gene therapy
      • Gene editing
    • Cancer
      • Preclinical research
      • Tissue engineering
      • 3D printing
      • Biobanking
    • Clinical trials & funding
      • Manufacturing & scale-up
      • Regulation & policy
      • Industry developments

    Follow us on social media

  • Features
    • The week in cell therapy
      • Spotlights
      • In Focus
      • Tech digest
    • Interviews
      • Opinion
      • Report
      • App Notes & White Papers
    • Find a partner
      • Events
      • Events coverage
      • The Glossary for Advanced Therapies

    Follow us on social media

  • Multimedia
    • eBooks
    • Webinars
    • Podcasts
    • Videos
    • Infographics

    Follow us on social media

  • Register

Welcome to RegMedNet

6 FEB 2026 CLINICAL TRIALS
Early phase iPSC therapy trial for Parkinson’s disease
6 FEB 2026 GENE THERAPY
Optimizing DNA delivery with nuclear localization signals
5 FEB 2026 CAR-T
Cell therapy weekly: advocacy groups push to restore Tecartus access
5 FEB 2026 AWARENESS
Research and progress in sickle cell disease and thalassemia: a podcast with Baba Inusa
3 FEB 2026 CAR-T
mRNA-based CAR-T therapy reduces symptom expression in myasthenia gravis
30 JAN 2026 NEWS
Stem cell survivorship bias: the key to understanding aging muscle repair
1 / 6

Sign up for our RegMedNet weekly news round-up

19 JAN 2026 FDA / ARTICLE
US FDA increases flexibility on CMC rules for cell and gene therapies
16 DEC 2025 PRECLINICAL RESEARCH / ARTICLE
Regenerative Medicine Highlights: October – December 2025
13 JAN 2026 INDUSTRY DEVELOPMENTS / ARTICLE
Industry updates with Dusko Ilic: December 2025

Image
Our Journals Journal Content

Journal Content

12 OCT 2025 Research Article / Regenerative Medicine

Comparison of 3D culture systems on mesenchymal stem cell longevity, regenerative potential,...

22 SEP 2025 Perspective / Regenerative Medicine

LGBTQ+ persons, queer bioethics, and inclusivity in stem cell research and regenerative...

13 AUG 2025 Editorial / Regenerative Medicine

Biological tendon regeneration, are we almost there or is it still a...

5 JUL 2025 Editorial / Regenerative Medicine

Current clinical applications of RNA-LNPs in regenerative medicine

6 JUN 2025 Research Article / Regenerative Medicine

Leveraging electric current stimulation and chemical induction to enhance MSC differentiation into...

29 MAY 2025 Review / Immunotherapy

Biology-driven therapies of CAR T immune effector cell-associated neurotoxicity syndrome

Featured

Image
5 FEB 2026 AWARENESS / PODCAST
Research and progress in sickle cell disease and thalassemia: a podcast with Baba Inusa
Image
28 NOV 2025 SPOTLIGHT
Spotlight on cell therapy sources and clinical applications
Image
15 OCT 2025 IN FOCUS
In Focus: AAV characterization and analysis for gene therapy
Image
25 SEP 2025 IN FOCUS
In Focus: Allogeneic cell therapy
Image
5 AUG 2025 IN FOCUS
In Focus: Supply chain
Image
19 JUN 2025 IN FOCUS
In Focus: iPSCs and MSCs
Image
17 APR 2025 SPOTLIGHT
Spotlight on gene therapy analytical testing
Image
7 MAR 2025 AWARENESS / PODCAST
Cell therapies for autoimmune diseases: a podcast with Lindsay Davies
Image
28 JAN 2025 IN FOCUS
In Focus: Scaling iPSC cultures
Image
7 JAN 2025 SPOTLIGHT
Spotlight on iPSCs

Must Watch

Image
30 JAN 2026 INTERVIEWS / VIDEO
Engineering MSC-derived exosome mimetics for bone regeneration: an interview with Jiabing Fan
Image
28 OCT 2025 CELL THERAPY / WEBINAR
Q&A highlights: Cell manufacturing with GMP ancillary material solutions from BioLegend
Image
12 AUG 2025 CELL THERAPY / WEBINAR
Cell manufacturing with GMP ancillary material solutions from BioLegend
Image
14 MAR 2025 MANUFACTURING & SCALE-UP / WEBINAR
Bridging platforms for enhanced & harmonized bioprocess data collaboration
Image
12 FEB 2025 CELL THERAPY / WEBINAR
From bench to patient care: unlocking iPSC potential through innovative science and strategic partnerships
Image
20 JAN 2025 GENE THERAPY / WEBINAR
USP Standards for plasmid DNA: quality control in cell and gene therapy
raw material quality for cell and gene therapies Regulatory standards in cell and gene therapies Regulatory compliant raw materials
23 SEP 2024 GENE THERAPY / WEBINAR
Decoding raw material quality and regulatory standards in cell and gene therapy
Cell and gene therapy manufacturing Cell therapy quality challenges GMP manufacturing of quality ancillary reagents for cell and gene therapy
23 JUL 2024 CELL THERAPY / WEBINAR
GMP manufacturing of quality ancillary reagents for cell and gene therapy
Image
1 MAY 2024 WEBINARS / WEBINAR
Best practices to maximize strategic partnerships in regenerative medicine
Image
7 MAR 2024 CELL THERAPY / VIDEO
Exosome production process development in stirred-tank bioreactors

What's Trending?

Image
8 JAN 2026 INDUSTRY DEVELOPMENTS / ARTICLE
Cell therapy weekly: in vivo CAR-T therapy moves forward
Image
21 JAN 2026 GENE EDITING / ARTICLE
CRISPR-Cas3: a potential therapeutic approach for genetic disorders?
Image
13 JAN 2026 MANUFACTURING & SCALE-UP / ARTICLE
From research to reality: how raw materials, media composition and process decisions shape T-cell therapies
Image
29 JAN 2026 INDUSTRY DEVELOPMENTS / ARTICLE
Cell therapy weekly: first IND cleared for AAV-based cancer therapy
Image
15 JAN 2026 INDUSTRY DEVELOPMENTS / ARTICLE
Cell therapy weekly: updates on CAR-T therapy for solid tumors
Image
22 JAN 2026 CELL THERAPY / ARTICLE
Cell therapy weekly: first iPSC therapy holding duo-combo recognition
  • About
  • Contact Us
  • Advertising & Sponsorship
  • Expert Panel
  • The Glossary for Advanced Therapies
  • Permissions
  • 3DMedLive Library
  • Accessibility

Contact

Contact Us

Office info

RegMedNet is powered by Taylor & Francis Group

RegMedNet, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 RegMedNet
Advertisement